Thanks for the transcript imtesty - It's always much more informative in print.

I thought that DM's presentation today was remarkable, given his circumstances. 

A site in Brazil is a perfect setting to conduct this trial currently. If apabetalone is effective in Brazil as the pandemic continues, breakthrough therapy status may quickly lead to an  emergency therapy and NDA. Winter is now beginning in Brazil the new Covid hotspot.

The Royalty arrangement described by DM offers Eversana a compelling and enormous incentive to get the word out and could very well be the door opener that this company needs. It also gives Resverlogix the leverage it needs for a much stronger negotiating position with BP and allows for the trial to be conducted without significant further dilution.

I am as frustrated as all on this board. It now looks like Covid or bust. Resolution is near.

If apabetalone is safe and the dual mechanism is proven to work in humans as described, this rocket may be lifting off soon.

I pray that it does - not only for myself but for all humanity.

Chicagoest